Nomura Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Nomura Holdings's BIIB Position: Q1 2026 in Review
Nomura Holdings reduced its Biogen (BIIB) stake by 89% in Q1 2026, selling an estimated $24.1M and leaving 16,730 shares worth $3.07M. The position accounts for 0.01% of the portfolio, ranked #793.
Nomura Holdings first reported a position in BIIB in Q2 2013 and has held it in 47 quarters since. The position peaked at $49.5M in Q3 2019. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Nomura Holdings held 16,730 shares of Biogen worth $3.07M as of Q1 2026.
- Nomura Holdings sold 130,531 Biogen shares in Q1 2026, an estimated $24.1M.
- Biogen made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #793 holding.
- Nomura Holdings first reported a position in Biogen in Q2 2013 and has held it in 47 quarters since.
- Nomura Holdings's Biogen position peaked at $49.5M in Q3 2019.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.